AUTL
Autolus Therapeutics
AUTL
AUTL
70 hedge funds and large institutions have $258M invested in Autolus Therapeutics in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 24 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $260M → $258M (-$2.15M)
42% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 24
Holders
70
Holding in Top 10
3
Calls
$368K
Puts
–
Top Buyers
| 1 | +$12.1M | |
| 2 | +$3.18M | |
| 3 | +$940K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$679K |
| 5 |
Renaissance Technologies
New York
|
+$286K |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$1.57M | |
| 3 | -$848K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$442K |
| 5 |
EAM
EdenTree Asset Management
London,
United Kingdom
|
-$430K |